Senores Pharma (SPL) shares jumped 3% after the company officially commenced operations at its cutting-edge Active Pharmaceutical Ingredient (API) manufacturing facility in Rajpur, Kadi, Mehsana, Gujarat. As of 9:35 AM, the shares were trading 3.32% higher at Rs 566.85.
Spanning an impressive 230,000 sq. ft., the new plant has an installed capacity of approximately 100 metric tons per annum. This expansion marks a significant milestone for Senores Pharma, reinforcing its position in the pharmaceutical industry.
As the company’s second API manufacturing facility, this greenfield project enhances production capabilities and ensures the supply of high-purity APIs to meet growing industry demands.
Swapnil Shah, Managing Director of Senores Pharmaceuticals Limited, said, We are delighted to commence operations at our greenfield state-of-the-art API facility atMehsana. Commissioning of this API facility will help Senores broaden its offerings andstrengthen its competitiveness in the Regulated Markets, especially in the CDMO/CMObusiness.”
Senores Pharma shares opened at ₹562.00 and hit a high of ₹585.00 before dipping to ₹555.50. The stock remains below its 52-week high of ₹644.80 but well above its low of ₹435.25.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.
